Aivado M, Gynes M, Gorelov V, Schmidt W U, Röher H D, Goretzki P E
Klinik für Allgemein- und Unfallchirurgie, Heinrich Heine-Universität Düsseldorf.
Chirurg. 2000 Oct;71(10):1230-4; discussion 1234-5. doi: 10.1007/s001040051207.
The c-K-ras2-gene (K-ras) encodes the p21ras protein, which participates in the transduction of mitogenic signals from the cell surface to the nucleus. About 40-50% of colorectal cancers bear a point mutation of the K-ras codon 12 within exon I, leading to activation of the K-ras oncogene.
Using a polymerase chain reaction (PCR)-based two-step restriction fragment length polymorphism (2sRFLP)-technique, we assessed the frequency of point mutations in the first or second base of K-ras codon 12 in patients suffering from colorectal carcinoma, adenoma, and their normal colon mucosa, respectively.
Similar to other investigators, we found mutations in 7 out of 17 (41%) colorectal carcinomas and 1 out of 4 (25%) adenomas. Using this very sensitive 2sRFLP technique (detection level = 0.2% of mutated cells), we were able to find K-ras codon 12 mutations in normal mucosa in 4 out of 18 (22.2%) patients with colorectal neoplasia.
This result can be explained by the phenomenon of "field cancerization" or by a local micrometastasis of K-ras-positive tumor cells.
c-K-ras2基因(K-ras)编码p21ras蛋白,该蛋白参与有丝分裂信号从细胞表面到细胞核的转导。约40%-50%的结直肠癌在外显子I内的K-ras密码子12处存在点突变,导致K-ras癌基因激活。
我们采用基于聚合酶链反应(PCR)的两步限制性片段长度多态性(2sRFLP)技术,分别评估了结直肠癌、腺瘤患者及其正常结肠黏膜中K-ras密码子12第一位或第二位碱基的点突变频率。
与其他研究者相似,我们在17例结直肠癌中有7例(41%)发现突变,在4例腺瘤中有1例(25%)发现突变。使用这种非常敏感的2sRFLP技术(检测水平=0.2%的突变细胞),我们在18例结直肠肿瘤患者中的4例(22.2%)的正常黏膜中发现了K-ras密码子12突变。
这一结果可以用“场癌化”现象或K-ras阳性肿瘤细胞的局部微转移来解释。